KRAS and colorectal cancer: Since the characterization of the KRAS miRNA-related SNP known as KRAS-LCS6 (rs61764370), there have been a number of studies on the relationship of its genotype with risk 13–18 and prognosis 19–28 of several cancers, with many such studies directed toward colorectal cancer outcome 19–26.